Yahoo Web Search

Search results

  1. At Sanofi, find our vaccines, including influenza, meningitis, pertussis, and more. Get prescribing information and patient resources.

  2. www.sanofi.com › en › your-healthVaccines - Sanofi

    Vaccines Help Protect Us. Every year, vaccination saves up to 5 million lives around the world. But an additional 1.5 million lives could be saved with improved vaccination coverage. 1. Why vaccines matter. Our Vaccines at a Glance. 500 million +. people vaccinated annually with our vaccines worldwide. 1.3 million.

  3. www.sanofi.com › en › our-scienceVaccines R&D - Sanofi

    For nearly 150 years, vaccines have provided high levels of protection against diseases that once ravaged entire populations. To stop infection in its tracks, our R&D teams develop vaccine antigens: molecules that help trigger the body’s immune response against disease-causing germs, or pathogens.

  4. Sanofi has been a leader in vaccines for over 100 years. The combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to de-velop new vaccines to address still unmet medical needs.

  5. May 17, 2021 · PARIS and LONDON – May 17, 2021 – The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult age groups in a Phase 2 study with 722 volunteers.

  6. Nov 10, 2015 · VidPrevtyn Beta is a monovalent, recombinant-protein next-generation COVID-19 vaccine developed by Sanofi, modelled on the Beta variant and including GSK’s pandemic adjuvant. The same recombinant-protein technology is used in Sanofi’s approved seasonal flu vaccines.

  7. Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare.

  8. Sep 28, 2021 · Sanofis mRNA-based COVID-19 vaccine candidate confirm the potential of recently- acquired Translate Bio’s messenger RNA (mRNA) and lipid nanoparticle (LNP) platform and support Sanofi’s mRNA strategy.

  9. Sanofi has been a leader in vaccines for over 100 years: the combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to develop new vaccines to address still unmet medical needs.

  10. May 22, 2024 · Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD. Read the Press Release. See all press releases. We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives.

  1. People also search for